Researchers at UW and Fred Hutch say unexplained federal funding denials have stalled promising efforts to personalize cancer treatment, forcing layoffs and slowing progress. The fallout extends beyond individual labs, raising concerns about disrupted clinical research, reduced training opportunities, and a weakened pipeline for future scientific innovation.
Cancer Research, More in Peril at University of Washington and Fred Hutch after Trump Cuts
Share: